|
Robert Swift conducts clinical and laboratory research on the causes of and treatments for alcoholism and drug dependence. He is particularly interested in how medications act to reduce craving and other potential endophenotypes of addictive disorders. He conducts clincal trials in patients with substance use disorders to investigate the efficacy of medications alone as well as medications combined with non-medical treatments such as counseling. He is also interested in the adoption of these new medications into medical practice.
Overview | Research | Grants/Awards | Teaching | Publications
Dr. Swift received his B.A., Ph.D. and M.D.(with honors)degrees from the University of Chicago. He completed a residency in Psychiatry at Yale University and is Board Certified in Psychiatry and in Addiction Psychiatry. He conducts clinical and laboratory research on the pharmacological treatment of alcohol and drug abuse and dependence. He is a recipient of research grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA) and from foundations and pharmaceutical companies. He is the site Principal Investigator for the NIAAA COMBINE Study, a cooperative clinical trial investigating combined pharmacotherapy and psychotherapy in the treatment of alcohol dependence, and he has a national role as the head of the Pharmacotherapy Subcommittee. He serves frequently as a member of advisory committees to government agencies and industry. He is a Distinguished Fellow of the American Psychiatric Association (APA), a member of the American College of Neuropsychopharmacology (ACNP), and the American Society of Addiction Medicine (ASAM), and is Secretary, a member of the Board of Directors and the Education Committee of the Research Society on Alcoholism.
|
 ROBERT SWIFT, M.D., Ph.D. http://research.brown.edu/myresearch/Robert_Swift Brown collaborators:
Collaborators at other institutions: Are you Robert Swift? Click here to edit your research profile. |
